HORIZONS protocol: a UK prospective cohort study to explore recovery of health and well-being in adults diagnosed with cancer

Claire Foster, Lynn Calman, Alison Richardson, Carl R May, Anne Rogers, Peter W Smith, Claire Foster, Lynn Calman, Alison Richardson, Carl R May, Anne Rogers, Peter W Smith

Abstract

Introduction: Understanding the impact of cancer and its treatment on people's everyday lives will help prepare people for what to expect, enable health professionals to predict likely recovery trajectories and shape care management according to needs. HORIZONS will recruit people awaiting treatment and follow them up at regular intervals to assess recovery of health and well-being.

Research questions: What impact does cancer diagnosis and treatment have on people's lives in the short, medium and long term? What are people's health and well-being outcomes, experiences and self-management activities over time across different cancer types and what influences these? How do people connect with and relate to others in mobilising resources that enable them to self-manage the consequences of cancer and treatment?

Methods and analysis: HORIZONS is a multicentre, prospective cohort study exploring recovery of health and well-being in 3000 people diagnosed with breast cancer (<50 years), non-Hodgkin's lymphoma or gynaecological cancer. Recruitment will take place across National Health Service (NHS) sites in the UK between September 2016 and March 2019, before primary treatment starts. Participants will be identified through clinical teams and invited to complete questionnaires including assessments of quality of life, symptoms and functioning (Quality of Life in Adult Cancer Survivors; European Organisation for Research and Treatment Consortium Core quality of life questionnaire, EORTC-QLQ-C30), health status (EuroQol-5 dimensions, EQ-5D), self-efficacy, social support, social networks and lifestyle. Clinical data will also be collected. Descriptive statistics will characterise outcomes. Changes over time will be investigated. Factors that may influence recovery and self-management will be included in regression models to determine which influence health and well-being and self-management.

Ethics and dissemination: Ethics and Health Research Authority approvals granted (IRAS Project ID: 202342, REC reference number 16/NW/0425). Adopted onto the National Institute for Health Research Clinical Research Network portfolio. We will engage with our Scientific Advisory Board, Tumour Specific Expert Panels, User Reference Group, Macmillan and the University of Southampton to ensure maximum publicity and benefit.

Trial registration: ClinicalTrials.gov NCT03000192.

Keywords: cancer survivorship; cohort; longitudinal; quality of life; recovery.

Conflict of interest statement

Competing interests: None declared.

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Figures

Figure 1
Figure 1
Conceptual framework underpinning the HORIZONS programme (informed by Foster and Fenlon, May et al, Vassilev et al 17)

References

    1. Maddams J, Utley M, Møller H. Projections of cancer prevalence in the United Kingdom, 2010-2040. Br J Cancer 2012;107:1195–202. 10.1038/bjc.2012.366
    1. May CR, Eton DT, Boehmer K, et al. . Rethinking the patient: using Burden of Treatment Theory to understand the changing dynamics of illness. BMC Health Serv Res 2014;14:281 10.1186/1472-6963-14-281
    1. Foster C, Fenlon D. Recovery and self-management support following primary cancer treatment. Br J Cancer 2011;105(Suppl 1):S21–8. 10.1038/bjc.2011.419
    1. Corner J, Wright D, Hopkinson J, et al. . The research priorities of patients attending UK cancer treatment centres: findings from a modified nominal group study. Br J Cancer 2007;96:875–81. 10.1038/sj.bjc.6603662
    1. Foster C, Wright D, Hill H, et al. . Psychosocial implications of living 5 years or more following a cancer diagnosis: a systematic review of the research evidence. Eur J Cancer Care 2009;18:223–47. 10.1111/j.1365-2354.2008.01001.x
    1. Jefford M, Karahalios E, Pollard A, et al. . Survivorship issues following treatment completion-results from focus groups with Australian cancer survivors and health professionals. J Cancer Surviv 2008;2:20–32. 10.1007/s11764-008-0043-4
    1. Hewitt M, Greenfield S, Stovall E. From cancer patient to cancer survivor: Lost in transition. Washington, DC: National Academies Press, 2005.
    1. Armes J, Crowe M, Colbourne L, et al. . Patients' supportive care needs beyond the end of cancer treatment: a prospective, longitudinal survey. J Clin Oncol 2009;27:6172–9. 10.1200/JCO.2009.22.5151
    1. Bell ML, Kenward MG, Fairclough DL, et al. . Differential dropout and bias in randomised controlled trials: when it matters and when it may not. BMJ 2013;346:e8668 10.1136/bmj.e8668
    1. Glaser AW, Fraser LK, Corner J, et al. . Patient-reported outcomes of cancer survivors in England 1-5 years after diagnosis: a cross-sectional survey. BMJ Open 2013;3:e002317 10.1136/bmjopen-2012-002317
    1. Breckons M, Calman L, Foster CL. An online survey to examine cancer survivors' confidence to self-manage problems arising in the first 12 months following primary cancer treatment. In: Report MSRG, ed, 2012.
    1. Santin O, Mills M, Treanor C, et al. . A comparative analysis of the health and well-being of cancer survivors to the general population. Support Care Cancer 2012;20:2545–52. 10.1007/s00520-011-1372-9
    1. van de Poll-Franse LV, Horevoorts N vanE. The Patient Reported Outcomes Following Initial treatment and Long term Evaluation of Survivorship registry: Scope, rationale and design of an infrastructure for the study of physical and psychosocial outcomes in cancer survivorship cohorts. Eur J Cancer 2011.
    1. Turner J, Kelly B, Clarke D, et al. . A tiered multidisciplinary approach to the psychosocial care of adult cancer patients integrated into routine care: the PROMPT study (a cluster-randomised controlled trial). Supportive Care in Cancer 2017;25:17–26. 10.1007/s00520-016-3382-0
    1. Gallacher K, May CR, Montori VM, et al. . Understanding patients' experiences of treatment burden in chronic heart failure using normalization process theory. Ann Fam Med 2011;9:235–43. 10.1370/afm.1249
    1. Vassilev I, Rogers A, Blickem C, et al. . Social networks, the ’work' and work force of chronic illness self-management: a survey analysis of personal communities. PLoS One 2013;8:e59723 10.1371/journal.pone.0059723
    1. Vassilev I, Rogers A, Kennedy A, et al. . The influence of social networks on self-management support: a metasynthesis. BMC Public Health 2014;14:719 10.1186/1471-2458-14-719
    1. Office for National Statistics.
    1. Ware J, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996;34:220–33.
    1. University of Essex, Institute for Social and Economic Research. Understanding Society: Waves 1-8, 2009-2017 and Harmonised BHPS: Waves 1-18, 1991-2009. [data collection]. UK Data Service. 11th edn: SN, 2018:6614.
    1. Avis NE, Smith KW, McGraw S, et al. . Assessing quality of life in adult cancer survivors (QLACS). Qual Life Res 2005;14:1007–23. 10.1007/s11136-004-2147-2
    1. EuroQol Group. EuroQol - a new facility for the measurement of health-related quality of life. Health Policy 1990;16:199–208. 10.1016/0168-8510(90)90421-9
    1. Herdman M, Gudex C, Lloyd A, et al. . Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res 2011;20:1727–36. 10.1007/s11136-011-9903-x
    1. Janssen MF, Pickard AS, Golicki D, et al. . Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study. Qual Life Res 2013;22:1717–27. 10.1007/s11136-012-0322-4
    1. Aaronson NK, Ahmedzai S, Bergman B, et al. . The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85:365–76. 10.1093/jnci/85.5.365
    1. van de Poll-Franse L, Oerlemans S, Bredart A, et al. . International development of four EORTC disease-specific quality of life questionnaires for patients with Hodgkin lymphoma, high- and low-grade non-Hodgkin lymphoma and chronic lymphocytic leukaemia. Qual Life Res 2018;27:333–45. 10.1007/s11136-017-1718-y
    1. Sprangers MA, Groenvold M, Arraras JI, et al. . The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. J Clin Oncol 1996;14:2756–68. 10.1200/JCO.1996.14.10.2756
    1. Greimel ER, Kuljanic Vlasic K, Waldenstrom AC, et al. . The European Organization for Research and Treatment of Cancer (EORTC) Quality-of-Life questionnaire cervical cancer module: EORTC QLQ-CX24. Cancer 2006;107:1812–22. 10.1002/cncr.22217
    1. Greimel E, Nordin A, Lanceley A, et al. . Psychometric validation of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Endometrial Cancer Module (EORTC QLQ-EN24). Eur J Cancer 2011;47:183–90. 10.1016/j.ejca.2010.08.014
    1. Greimel E, Bottomley A, Cull A, et al. . An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-OV28) in assessing the quality of life of patients with ovarian cancer. Eur J Cancer 2003;39:1402–8. 10.1016/S0959-8049(03)00307-1
    1. Jensen P, Froeding L, Greimel E, et al. . Development and pre-testing of the EORTC quality of life questionnaire for vulva cancer patients – the significance of patient involvement. Int J Gynecol Cancer 2017;27(S4):1770–70.
    1. EORTC Item Library [ONLINE].
    1. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361–70. 10.1111/j.1600-0447.1983.tb09716.x
    1. Moorey S, Greer S, Watson M, et al. . The factor structure and factor stability of the hospital anxiety and depression scale in patients with cancer. Br J Psychiatry 1991;158:255–9. 10.1192/bjp.158.2.255
    1. Clark A, Fallowfield LJ. Quality of life measurements in patients with malignant disease: a review. J R Soc Med 1986;79:165–9. 10.1177/014107688607900311
    1. Sherbourne CD, Stewart AL. The MOS social support survey. Soc Sci Med 1991;32:705–14. 10.1016/0277-9536(91)90150-B
    1. Lorig KR, Ritter P, Stewart AL, et al. . Chronic disease self-management program: 2-year health status and health care utilization outcomes. Med Care 2001;39:1217–23.
    1. Foster C, Breckons M, Hankins M, et al. . Developing a scale to measure self-efficacy to SELF-manage problems following cancer treatment. Psycho-Oncology 2013;22:16.
    1. Osborne RH, Elsworth GR, Whitfield K. The Health Education Impact Questionnaire (heiQ): an outcomes and evaluation measure for patient education and self-management interventions for people with chronic conditions. Patient Educ Couns 2007;66:192–201. 10.1016/j.pec.2006.12.002

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi